Search Results - "shuhui deng" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Venetoclax Resistance Results in Broad Resistance to Majority of Anti-MM Agents Due to the Suppression of Apoptosis but Can be Overcome By BCMA-Targeted Immunotherapy

Venetoclax Resistance Results in Broad Resistance to Majority of Anti-MM Agents Due to the Suppression of Apoptosis but Can be Overcome By BCMA-Targeted Immunotherapy

by Fulciniti, Mariateresa, Deng, Shuhui, Dereibal, Sanika, Weiler, Vera Joy, Chatterjee, Madhumouli, Ng Fong, Jessica, Chakraborty, Chandraditya, Prabhala, Rao, Shammas, Masood A., Aktas-Samur, Anil, Samur, Mehmet K., Gulla, Annamaria, Anderson, Kenneth C., Munshi, Nikhil C
Published in Blood (02.11.2023)

Get full text

Journal Article

Promising Safety and Efficacy of Trovocabtagene Autoleucel (C-CAR088) Followed ASCT in Ultra High-Risk Multiple Myeloma (UHR-MM) Patients Who Failed or Had Suboptimal Response to Standard First Line Triplet Based Therapy

Promising Safety and Efficacy of Trovocabtagene Autoleucel (C-CAR088) Followed ASCT in Ultra High-Risk Multiple Myeloma (UHR-MM) Patients Who Failed or Had Suboptimal Response to Standard First Line Triplet Based Therapy

by Xu, Yan, Li, Wensi, An, Gang, Sui, Weiwei, Deng, Shuhui, Wang, Tingyu, Yi, Shuhua, Huang, Wenyang, Liu, Wei, Wang, Qi, Lv, Rui, Xiong, Wenjie, Du, Chenxing, Zhu, Judy, Huang, Jiaqi, Zheng, Chengxiao, Lan, Liping, Zhu, Kevin, Qiu, Lugui, Zou, Dehui
Published in Blood (02.11.2023)

Get full text

Journal Article

Safety and Efficacy of GBC/GBM Conditioning Regimen Followed By Autologous Stem Cell Transplantation in Lymphoid Malignancies

Safety and Efficacy of GBC/GBM Conditioning Regimen Followed By Autologous Stem Cell Transplantation in Lymphoid Malignancies

by Liu, Huimin, Liu, Wei, Li, Ru, Huang, Wenyang, Yi, Shuhua, Lv, Ryu, Deng, Shuhui, An, Gang, Qiu, Lugui, Zou, Dehui
Published in Blood (05.11.2020)

Get full text

Journal Article

$Anti-CD19 CAR T-Cell (CNCT19) Infusion Following HDT/ASCT Is Safe and Effective in Patients with Relapsed/Refractory Large B-Cell Lymphoma$

Anti-CD19 CAR T-Cell (CNCT19) Infusion Following HDT/ASCT Is Safe and Effective in Patients with Relapsed/Refractory Large B-Cell Lymphoma

by Liu, Wei, Huang, Wenyang, Lv, Ryu, Deng, Shuhui, Yi, Shuhua, Liu, Huimin, Lv, Lulu, Qiu, Lugui, Zou, Dehui, Wang, Jianxiang
Published in Blood (05.11.2020)

Get full text

Journal Article

Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma

Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma

by Shi, Lihui, Qin, Xiaoqi, Wang, Huijun, Xia, Yonghui, Li, Yuanyuan, Chen, Xuejing, Shang, Lei, Tai, Yu-Tzu, Feng, Xiaoyan, Acharya, Prakrati, Acharya, Chirag, Xu, Yan, Deng, Shuhui, Hao, Mu, Zou, Dehui, Zhao, Yaozhong, Ru, Kun, Qiu, Lugui, An, Gang
Published in Oncotarget (21.03.2017)

Get full text

Journal Article

The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteria

The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteria

by Yan, Wenqiang, Fan, Huishou, Xu, Jingyu, Liu, Jiahui, Li, Lingna, Du, Chenxing, Deng, Shuhui, Sui, Weiwei, Hao, Mu, Yi, Shuhua, Zou, Dehui, Qiu, Lugui, Xu, Yan, An, Gang
Published in Leukemia & lymphoma (15.10.2022)

Get full text

Journal Article

Clonal Heterogeneity and Evolutionary Phylogeny of Critical Cytogenetic Aberrations in Multiple Myeloma

Clonal Heterogeneity and Evolutionary Phylogeny of Critical Cytogenetic Aberrations in Multiple Myeloma

by Yan, Yuting, Qin, Xiaoqi, Liu, Jiahui, Fan, Huishou, Liu, Lanting, Yu, Zhen, Deng, Shuhui, Liu, Wei, Zou, Dehui, Qiu, Lugui, An, Gang
Published in Blood (23.11.2021)

Get full text

Journal Article

Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation

Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation

by Xu, Jingyu, Yan, Wenqiang, Fan, Huishou, Liu, Jiahui, Li, Lingna, Du, Chenxing, Deng, Shuhui, Sui, Weiwei, Xu, Yan, Qiu, Lugui, An, Gang
Published in Annals of hematology (01.11.2023)

Get full text

Journal Article

P-191 Acquisition of venetoclax resistance is characterized by higher expression of anti-apoptotic regulators, less mitochondrial priming, and broader resistance to anti-MM agents

P-191 Acquisition of venetoclax resistance is characterized by higher expression of anti-apoptotic regulators, less mitochondrial priming, and broader resistance to anti-MM agents

by Fulciniti, Mariateresa, Ng, Jessica Fong, Weiler, Joy, Deng, Shuhui, Chakraborty, Chandraditya, Samur, Mehmet, Gulla, Annamaria, Anderson, Kenneth, Munshi, Nikhil
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)

Get full text

Journal Article

Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing

Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing

by Cui, Jian, Li, Xiaoyun, Deng, Shuhui, Du, Chenxing, Fan, Huishou, Yan, Wenqiang, Xu, Jingyu, Li, Xiaoqing, Yu, Tengteng, Zhang, Shuaishuai, Lv, Rui, Sui, Weiwei, Hao, Mu, Du, Xin, Xu, Yan, Yi, Shuhua, Zou, Dehui, Cheng, Tao, Qiu, Lugui, Gao, Xin, An, Gang
Published in Clinical cancer research (03.09.2024)

Get full text

Journal Article

Risk of hepatitis B reactivation is controllable in patients with B‐cell lymphoma receiving anti‐CD19 CAR T cell therapy

Risk of hepatitis B reactivation is controllable in patients with B‐cell lymphoma receiving anti‐CD19 CAR T cell therapy

by Liu, Wei, Huang, Wenyang, Wang, Min, Lv, Rui, Li, Jian, Wang, Ying, Deng, Shuhui, Yi, Shuhua, Liu, Hong, Rao, Qing, Xu, Yingxi, Lv, Lulu, Qiu, Lugui, Zou, Dehui, Wang, Jianxiang
Published in British journal of haematology (01.10.2020)

Get full text

Journal Article

A Retrospective, Matched Paired Analysis Comparing GBM/GBC Versus BEAM/Beac Conditioning Regimen for Autologous Stem Cell Transplantation in Non-Hodgkin's Lymphoma

A Retrospective, Matched Paired Analysis Comparing GBM/GBC Versus BEAM/Beac Conditioning Regimen for Autologous Stem Cell Transplantation in Non-Hodgkin's Lymphoma

by Liu, Huimin, Zou, Hesong, Liu, Wei, Huang, Wenyang, Deng, Shuhui, Lv, Rui, Sui, Weiwei, Xu, Yan, Yi, Shuhua, Wang, Tingyu, Fu, Mingwei, An, Gang, Zhao, Yaozhong, Qiu, Lugui, Zou, Dehui
Published in Blood (15.11.2022)

Get full text

Journal Article

Development of a Clinical Risk Stratification for Patients with Newly Diagnosed Multiple Myeloma

Development of a Clinical Risk Stratification for Patients with Newly Diagnosed Multiple Myeloma

by Mao, Xuehan, Xu, Yan, Yan, Yuting, Liu, Jiahui, Fan, Huishou, Sui, Weiwei, Deng, Shuhui, Li, Zengjun, Qiu, Lugui, An, Gang
Published in Blood (13.11.2019)

Get full text

Journal Article

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

by Liu, Wei, Lv, Rui, Huang, Wenyang, Liu, Hong, Deng, Shuhui, Yi, Shuhua, Lv, Lulu, Wang, Jianxiang, Qiu, Lugui, Zou, Dehui
Published in Blood (13.11.2019)

Get full text

Journal Article

Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)

Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)

by Fan, Huishou, Wang, Bing, Shi, Lihui, Pan, Ni, Yan, Wenqiang, Xu, Jingyu, Gong, Lixin, Li, Lingna, Liu, Yuntong, Du, Chenxing, Cui, Jian, Zhu, Guoqing, Deng, Shuhui, Sui, Weiwei, Xu, Yan, Yi, Shuhua, Hao, Mu, Zou, Dehui, Chen, Xiequn, Qiu, Lugui, An, Gang
Published in Clinical cancer research (15.03.2024)

Get full text

Journal Article

The bone marrow microenvironment of multiple myeloma promotes myeloma related anemia by suppressing the differentiation of hematopoietic stem cells

The bone marrow microenvironment of multiple myeloma promotes myeloma related anemia by suppressing the differentiation of hematopoietic stem cells

by liu, lanting, hao, mu, deng, shuhui, Qiu, Lugui, Yu, Zhen
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)

Get full text

Journal Article

Prognostic Impact of Hyperdiploidy on Multiple Myeloma in the Era of New Agents

Prognostic Impact of Hyperdiploidy on Multiple Myeloma in the Era of New Agents

by Wang, Yi, Zhuang, Jing, An, Gang, Mao, Xue-Han, Du, Chenxing, Liu, Jiahui, Fan, Huishou, Deng, Shuhui, Xu, Yan, Sui, Weiwei, Qiu, Lugui
Published in Blood (05.11.2020)

Get full text

Journal Article

Multiple Myeloma Cell Defects Erythropoiesis and Results Anemia Via High Level of CCL3 in Bone Marrow Microenvironment

Multiple Myeloma Cell Defects Erythropoiesis and Results Anemia Via High Level of CCL3 in Bone Marrow Microenvironment

by Liu, Lanting, Yu, Zhen, Cheng, Hui, Sui, Weiwei, Deng, Shuhui, Wei, Xiaojing, Du, Chenxing, Huang, Wenyang, An, Gang, Zhou, Wen, Cheng, Tao, Qiu, Lugui, Hao, Mu
Published in Blood (05.11.2020)

Get full text

Journal Article

Igh Translocation with Undefined Partners Is Associated with Superior Outcome in Multiple Myeloma Patients

Igh Translocation with Undefined Partners Is Associated with Superior Outcome in Multiple Myeloma Patients

by Mao, Xue-Han, Xu, Yan, Yan, Yuting, Zhuang, Junling, Fan, Huishou, Sui, Weiwei, Liu, Jiahui, Deng, Shuhui, Yi, Shuhua, Qiu, Lugui, An, Gang
Published in Blood (05.11.2020)

Get full text

Journal Article

Development and Analysis of a Weighed Prognostic Model in Newly Diagnosed Multiple Myeloma Patients

Development and Analysis of a Weighed Prognostic Model in Newly Diagnosed Multiple Myeloma Patients

by Mao, Xue-Han, Xu, Yan, Yan, Yuting, Liu, Jiahui, Fan, Huishou, Sui, Weiwei, Deng, Shuhui, Du, Chenxing, Zou, Dehui, Qiu, Lugui, An, Gang
Published in Blood (05.11.2020)

Get full text

Journal Article

[1]
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
[12]